{
  "pdfPath": "/home/arkantu/Documentos/Zotero Biblioteca/Genetica/Recesivas/Wierenga et al. - 2013 - A clinical evaluation tool for SNP arrays, especially for autosomal recessive conditions in offsprin.pdf",
  "fileName": "Wierenga et al. - 2013 - A clinical evaluation tool for SNP arrays, especially for autosomal recessive conditions in offsprin.pdf",
  "relativePath": "Genetica/Recesivas/Wierenga et al. - 2013 - A clinical evaluation tool for SNP arrays, especially for autosomal recessive conditions in offsprin.pdf",
  "text": "ORIGINAL RESEARCH ARTICLE                                                                ©American College of Medical Genetics and Genomics\n\n                                                                                                                                                                  Open\n\n\n               A clinical evaluation tool for SNP arrays, especially\n                for autosomal recessive conditions in offspring\n                            of consanguineous parents\n          Klaas J. Wierenga, MD, MSc1, Zhijie Jiang, PhD2, Amy C. Yang, MD3, John J. Mulvihill, MD1\n                                     and Nicholas F. Tsinoremas, PhD2\n\n\n Purpose: This report describes a fast online tool to accelerate and                     Conclusion: The online single nucleotide polymorphism array\n improve clinical interpretation of single nucleotide polymorphism                       evaluation tool rapidly and systematically identifies relevant genes\n array results for diagnostic purposes, when consanguinity or inbreed-                   and associated conditions mapping to identified regions of homozy-\n ing is identified.                                                                      gosity. The built-in OMIM clinical feature search allows the user to\n                                                                                         further filter to reach a short list of candidate conditions relevant for\n Methods: We developed a web-based program that permits entry\n                                                                                         the diagnosis, making it possible to strategize more focused diagnos-\n of regions of homozygosity and, using OMIM, UCSC, and NCBI\n                                                                                         tic testing. The tabulated results can be downloaded and saved to the\n databases, retrieves genes within these regions as well as their asso-\n                                                                                         desktop in an Excel format. Its efficacy is illustrated by providing a\n ciated autosomal recessive disorders. Relevant OMIM Clinical Syn-\n                                                                                         few clinical examples.\n opses can be searched, using key clinical terms permitting further\n filtering for candidate genes and disorders.                                            Genet Med 2013:15(5):354–360\n Results: The tool aids the clinician by arriving at a short list of\n                                                                                         Key Words: consanguinity; homozygosity; inbreeding; OMIM;\n relevant candidate disorders, guiding the continued diagnostic\n ­\n                                                                                         SNP array\n ­work-up. Its efficacy is illustrated by presenting seven patients who\n  were diagnosed using this tool.\n\n\n\n                            INTRODUCTION                                                 isolation expected to result in inbreeding. Consanguinity is\nThe molecular basis of Mendelian traits continues to be clarified                        an ancient cultural practice that is common in many regions\nas new technologies improve the classic strategies of gene map-                          of the world, especially in the Middle East and parts of Asia.4\nping and mutation detection, producing insights with just a few                          Individuals born into such families typically have long runs\npatients with a rare disorder.1,2 This increase in knowledge is a                        (or regions) of homozygosity (ROHs), with the combined\npromising development, fueling the expectation that patients                             length a function of the degree of relatedness of the parents,\nand their families will benefit from unraveling the molecular                            expressed as ROHtotal = F × sizehg (sizehg = size of the haploid\nbasis of these disorders. However, this improved knowledge is                            human genome, or ~3,200 Mb). The coefficient of inbreed-\nfrequently not met by an increased capability of the clinician                           ing, F, is defined as the fraction of the individual’s genome\nto recognize, identify, and diagnose patients with these many                            expected to be homozygous by descent. Because F is 1/16 in\nrare disorders.3 This conundrum, in our opinion, is largely due                          the offspring of first-cousin parents, the calculated ROHtotal\nto the fact that the genetics evaluation is still predominantly                          is 200 Mb. It is well known that such individuals are at an\nphenotype-oriented. Therefore, the clinician’s experience and                            increased risk for autosomal recessive disorders, with the\nengagement are important variables, contributing to the lack                             mutated locus being typically homozygous and expected to\nof recognition of signs and symptoms (patterns) if the phe-                              reside in a ROH. This risk (α) can actually be estimated using\nnotype is rare or atypical. Clearly, innovative and more effec-                          α = F/(F + (1 − F)q), where q is the frequency of the mutant\ntive approaches are needed to achieve a timely diagnosis, to                             allele.5,6 In an inbred or consanguineous family, q will be\noptimize management, to identify action for surveillance and                             small as compared with F, and α therefore close to 1, which\nanticipatory guidance, to communicate recurrence risk, and to                            implies that the disease-causing mechanism is highly likely\ncounsel regarding reproductive options.                                                  due to homozygosity by descent.5,6 The single nucleotide poly-\n   Most medical genetics units serve families with obvi-                                 morphism (SNP) array, a genomic microarray platform, can\nous consanguinity and from communities with geographic                                   identify these various ROHs. Through analysis of these ROHs,\n\nThe first two authors contributed equally to this work.\n1\n Section of Genetics, Department of Pediatrics, University of Oklahoma, Oklahoma City, Oklahoma, USA; 2Center for Computational Science, University of Miami, Miami,\nFlorida, USA; 3Division of Medical Genetics, Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, USA.\nCorrespondence: Klaas J. Wierenga (Klaas-Wierenga@ouhsc.edu)\nSubmitted 25 June 2012; accepted 10 September 2012; advance online publication 1 November 2012. doi:10.1038/gim.2012.136\n\n354                                                                                                           Volume 15 | Number 5 | May 2013 | GENETICS in MEDICINE\n\fEvaluation tool for SNP arrays | WIERENGA et al                                                 ORIGINAL RESEARCH ARTICLE\n\n\n\n\nFigure 1 Input of relevant data into the search page of the single nucleotide polymorphism (SNP) array evaluation tool. In this example, three\nregions of homozygosity (ROHs) identified by SNP array analysis are placed into the text box, one ROH per line, after which the user selects the location unit\n(base, kb, and/or Mb) and the version of the Human Genome Assembly as stated in the SNP array analysis report. The user then selects the query type, here\nROH (microdeletion/microduplication option not discussed here). The user then selects the query depth, typically for autosomal recessive disorders in the setting\nof consanguinity. The user may filter further by performing a clinical features search using an OMIM Clinical Synopsis search string (using search terms, often\nusing wildcards, combined with Boolean operators).\n\nwe can evaluate for autosomal recessive disorders associated                      Biotechnology Information (NCBI) database, to rapidly iden-\nwith genes that map to these regions. This would therefore                        tify the genes mapping to the ROHs (as given in the original\nconstitute a meaningful approach to identify candidate genes                      SNP array report), to enumerate associated autosomal reces-\nand associated disorders. In Saudi Arabia, where consanguin-                      sive clinical disorders and their clinical features, and to match\nity is common, the usefulness of an SNP array analysis early                      the clinical features of the patient being evaluated against these\nin the diagnostic evaluation of a phenotype with genetic het-                     phenotypes. We further demonstrate the clinical utility in seven\nerogeneity has been demonstrated, thus making the diagnosis                       recent patients, accrued in just a few months. Another case has\nin a more targeted manner and with less cost.7 However, it                        been reported elsewhere.8\ncan take a skilled genetics professional several hours to query\ngenetic databases to evaluate ROHs that total 200 Mb for can-                                      MATERIALS AND METHODS\ndidate genes and associated disorders.                                            Our online SNP array evaluation tool, based on the\n   On the basis of our clinical experience and realizing that                     Common Gateway Interface, uses Practical Extraction and\nthe time needed to manually interrogate all ROHs thoroughly                       Report Language (Perl) to handle hypertext transfer pro-\nusing current databases is prohibitive, we developed a com-                       tocol (HTTP) requests and responses. The graphic user\nputer algorithm to systematically search through relevant                         interface is implemented using hypertext markup lan-\ngenetic databases, including the Online Mendelian Inheritance                     guage (HTML), cascading style sheets, and JavaScript and\nin Man (OMIM) database, the University of California at Santa                     delivered to client servers using an Apache 2 HTTP server.\nCruz Genome Browser (UCSC), and the National Center for                           The approach chosen in our tool is quite different from the\n\nGENETICS in MEDICINE | Volume 15 | Number 5 | May 2013                                                                                                      355\n\fORIGINAL RESEARCH ARTICLE                                                                                            WIERENGA et al | Evaluation tool for SNP arrays\n\n\n\n\nFigure 2 Single nucleotide polymorphism array evaluation tool report of search. The report of the search, returned in hypertext markup language\nand downloadable in a tabulated Excel spreadsheet format, provides coefficients of inbreeding (F) and consanguinity (f), the genes identified (given a certain\nsearch depth), their associated phenotypes and hypertext links to the OMIM genes and their disorders. University of California at Santa Cruz and National\nCenter for Biotechnology Information annotations.\n\n\nconventional way of using various individual online genetics                     Because some OMIM entries have no Clinical Synopsis (and\nbrowsers, such as the Database of Genomic Variants and the                       hence also no documented mode of inheritance), a search\nUCSC Genome Browser, where users manually scrutinize                             through annotation text for clinical features in OMIM genes is\ncandidate genes for a single ROH at a time; in contrast, our                     an available, although less reliable option. Separately, a special\ntool can systematically search candidate genes on multiple                       option permits entry of specific genes of interest, using either\n(theoretically unlimited) ROHs, using several genetic data-                      the official gene symbol or gene identification number. This is\nbases. Currently, login privileges are granted by e-mail regis-                  an option for users who have “favorite gene” lists, for example,\ntration at http://www.ccs.miami.edu/ROH.                                         for conditions with locus heterogeneity (e.g., retinitis pigmen-\n  To conduct a search (Figure 1), after clinical evaluation and                  tosa and Bardet–Biedl syndrome).\nreceipt of a SNP array report, preferably as an electronic file                     The report of the search (Figure 2), returned in HyperText\nto facilitate “cut” and “paste” of the nucleotide addresses, the                 Markup Language, is downloadable in an Excel spreadsheet for-\nuser enters the coordinates of the various ROHs (in bases, kb,                   mat with tabs corresponding to the result sections. The result\nor Mb) and selects the Human Genome Assembly (hg) v­ ersion                      page also provides the calculated coefficients of inbreeding (F)\nstated in the report. The tool then automatically converts the                   and consanguinity (f) using the formulae F = ROHtotal/sizehg\ncoordinates to hg19 if an older hg version was used in the SNP                   (sizehg = 3,138 Mb in hg19) and f = 2F. Also provided are the\narray report. The user picks one depth of the search: (i) all                    genes identified (given a certain search depth), their associated\ngenes, (ii) OMIM-annotated genes, (iii) OMIM-annotated                           phenotypes, and hypertext links to the OMIM entries with the\ngenes associated with disorders (Morbid Map genes), or (iv)                      NCBI and UCSC annotations. In our experience, using relevant\nMorbid Map genes associated with autosomal dominant                              clinical features, the user usually arrives at a short list of candi-\ntraits or Morbid Map genes associated with autosomal reces-                      date genes and disorders for review and ranking. The user can\nsive traits. For the last three options, the user can provide the                then strategize the continued diagnostic approach, now focused\npatient’s key clinical features (phenotype) to refine the search,                on a small selection of likely relevant genes and disorders.\nusing Boolean operators “AND,” “OR,” and “NOT” to formulate                         Cases solved through the use of the SNP array evalua-\nan efficient search string from the “OMIM Clinical Synopsis.”                    tion tool were not collected systematically, as the SNP array\n\n356                                                                                                 Volume 15 | Number 5 | May 2013 | GENETICS in MEDICINE\n\f           Evaluation tool for SNP arrays | WIERENGA et al                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ORIGINAL RESEARCH ARTICLE\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                evaluation tool went through various stages of development,\n                                                                                                                                                                                                                  D-bifunctional protein\n\n\n\n\n                                                                                                                                                                                                                                                                                              Infantile neuroaxonal\n\n\n                                                                                                                                                                                                                                                                                                                             syndrome B, 252920\n\n\n                                                                                                                                                                                                                                                                                                                                                       biochemical studies,\n                                                                                                                                                                                                                                           3-Methylglutaconic\n                                                                                                                                                                                                                  deficiency, 261515\n\n\n\n\n                                                                                                                                                                                                                                                                     syndrome, 209900\n\n\n                                                                                                                                                                                                                                                                                              dystrophy, 256600\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                               syndrome, 209900\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                making cases hard to compare even if accrued in one institu-\nTable 1 Family history, presentation, clinical and initial laboratory impression, SNP array results, tool report (gene short list), final (homozygous) mutation,\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                       Lysinuric protein\n                                                                                                                                                                                                                                           aciduria type 1,\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                tion. One case was recruited from another institution as par-\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                       intolerance, by\n                                                                                                                                                                                                                                                                     Bardet–Biedl\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                               Bardet–Biedl\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ticularly illustrative. Sanger sequencing of relevant genes was\n                                                                                                                                                                                 Diagnosis,\n                                                                                                                                                                                 OMIM no.\n\n\n\n\n                                                                                                                                                                                                                                                                                                                             Sanfilippo\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                performed in commercial or academic, US-based, Clinical\n                                                                                                                                                                                                                                           250950\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                       222700\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Laboratory Improvement Amendments (CLIA)-certified labo-\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ratories unless stated otherwise.\n                                                                                                                                                                                                                                                                     (IVS6+1G→A)\n                                                                                                                                                                                                                                                                     c624+1G→A\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                               c.1169T→G\n                                                                                                                                                                                                                                                                                              c.2098C→T\n\n                                                                                                                                                                                                                                                                                                                             c.1811C→T\n\n\n                                                                                                                                                                                                                                                                                                                                                       unavailable\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          RESULTS\n                                                                                                                                                                                                                                           c.373C→T\n                                                                                                                                                                                 mutation\n\n                                                                                                                                                                                                                  c.296insA\n                                                                                                                                                                                                                  HSD17B4\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                       Mutation\n                                                                                                                                                                                                                                                                                              PLA2G6\n\n                                                                                                                                                                                                                                                                                                                             NAGLU,\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Principles and procedures are illustrated on the basis of\n\n\n\n                                                                                                                                                                                                                                                                                                                                                       studies\n                                                                                                                                                                                 Gene\n\n\n\n\n                                                                                                                                                                                                                                                                     TTC8,\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                               BBS1,\n                                                                                                                                                                                                                                           AUH,\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                seven recent patients and their families (Table 1). The patient\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                group, ranging from newborns to 12-year-olds, presented\n                                                                                                                                                                                                                                                                                                                                                       ASL, SLC7A7,\n                                                                                                                                                                                                   Tool report,\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                with ­common issues for clinical geneticists: abnormal new-\n                                                                                                                                                                                                                                           AUH, OPA3\n                                                                                                                                                                                                                  HSD17B4,\n                                                                                                                                                                                                   short list\n\n\n\n\n                                                                                                                                                                                                                                                                                              PLA2G6,\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                born screening results, hypotonia, developmental delay, fail-\n                                                                                                                                                                                                                                                                                                                             NAGLU\n                                                                                                                                                                                                                                                                                              COX15\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                       PCCA\n                                                                                                                                                                                     mutated locus gene\n\n\n                                                                                                                                                                                                                  GBE1\n\n\n\n\n                                                                                                                                                                                                                                                                     TTC8\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                               BBS1\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ure to thrive, neurologic regression, or obesity. A few patients\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                had other features that suggested a specific condition (poly-\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                dactyly and hypogonadism consistent with Bardet–Biedl syn-\n                                                                                                                                                                                      ROH with\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                drome) or category of metabolic disorder (hyperammonemia\n                                                                                                                                                                                       (in Mb)\n                                                                                                                                                                                                                  21.2\n\n                                                                                                                                                                                                                                           14.0\n\n\n                                                                                                                                                                                                                                                                     14.1\n\n\n                                                                                                                                                                                                                                                                                              18.7\n\n                                                                                                                                                                                                                                                                                                                             11.0\n\n                                                                                                                                                                                                                                                                                                                                                       10.7\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                               33.0\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                suggesting a urea cycle defect; coarse facies pointing to a stor-\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                age disorder). For the two cases of Bardet–Biedl syndrome,\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                the tool correctly identified the one candidate gene that lay\n                                                                                                                                                                   SNP array report,\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                within the ROH out of 18, obviating a tedious, expensive\n                                                                                                                                                                    (ROHs > 1 Mb)\n                                                                                                                                                                     ROHs > 8 Mb\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                search by serially sequencing all candidate genes. In all cases,\n                                                                                                                                                                                                                  191 (363)\n\n                                                                                                                                                                                                                                           261 (374)\n\n\n                                                                                                                                                                                                                                                                     207 (316)\n\n\n                                                                                                                                                                                                                                                                                              179 (311)\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                       299 (435)\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                               145 (287)\n                                                                                                                                                                                                                                                                                                                             38 (134)\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                the diagnostic odyssey ended and families were counseled\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                regarding the diagnosis, the recurrence risk, and the avail-\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ability of prenatal diagnosis for future pregnancies. In one\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                case (patient 6), the newly assigned diagnosis led to change\n                                                                                                                                                                                                                                           3-methylglutaconic acid\n\n\n\n\n                                                                                                                                                                                                                                                                                                                                                                   ",
  "wordCount": 4738,
  "indexed": "2025-09-25T22:42:41.420Z",
  "method": "direct"
}
